CenteneCNC
About: Centene is a managed care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%). The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program and has a military contract.
Employees: 67,700
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
13% more funds holding in top 10
Funds holding in top 10: 8 [Q2] → 9 (+1) [Q3]
1% more capital invested
Capital invested by funds: $35.4B [Q2] → $35.8B (+$444M) [Q3]
6% less first-time investments, than exits
New positions opened: 89 | Existing positions closed: 95
2% less funds holding
Funds holding: 879 [Q2] → 861 (-18) [Q3]
9.34% less ownership
Funds ownership: 99.89% [Q2] → 90.55% (-9.34%) [Q3]
14% less repeat investments, than reductions
Existing positions increased: 299 | Existing positions reduced: 348
28% less call options, than puts
Call options by funds: $226M | Put options by funds: $314M
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
11 analyst ratings
JP Morgan John Stansel 100% 1-year accuracy 1 / 1 met price target | 18%upside $75 | Overweight Assumed | 17 Dec 2024 |
Stephens & Co. Scott Fidel 51% 1-year accuracy 21 / 41 met price target | 15%upside $73 | Equal-Weight Maintained | 13 Dec 2024 |
Truist Securities Ryan MacDonald 56% 1-year accuracy 38 / 68 met price target | 32%upside $84 | Buy Maintained | 13 Dec 2024 |
Barclays Andrew Mok 29% 1-year accuracy 18 / 62 met price target | 47%upside $93 | Overweight Maintained | 13 Dec 2024 |
Oppenheimer Michael Wiederhorn 38% 1-year accuracy 15 / 40 met price target | 34%upside $85 | Outperform Maintained | 13 Dec 2024 |
Financial journalist opinion
Based on 10 articles about CNC published over the past 30 days